Pyrazines as delta opioid receptor modulators

Details for Australian Patent Application No. 2010313392 (hide)

Owner Janssen Pharmaceutica NV

Inventors Connolly, Peter J.; Lin, Shu-Chen; Macielag, Mark J.; Zhang, Yue-Mei

Agent Shelston IP

Pub. Number AU-A-2010313392

PCT Pub. Number WO2011/053696

Priority 61/256,392 30.10.09 US

Filing date 28 October 2010

Wipo publication date 5 May 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053696 Priority application(s): WO2011/053696

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313395-sORF constructs and multiple gene expression

2010313389-Intraluminal device with improved flexibility and durability